CAV1 and atherosclerosis: Engel et al. demonstrated that Cav-1 deficiency mitigates atherosclerosis by attenuating inflammation, reducing leukocyte infiltration, and decreasing plaque size, while fostering an anti-inflammatory regulatory T-cell response [186].